ATE166056T1 - Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten - Google Patents

Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten

Info

Publication number: ATE166056T1
Authority: AT; Austria
Prior art keywords: pct; production; pharmaceutical compositions; compositions containing; iii complexes
Prior art date: 1991-07-25

Application number

AT92916381T

Other languages

English (en)

Inventor

Philippe Collery

Bernhard Keppler

Original Assignee

Philippe Collery

Bernhard Keppler

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-07-25

Filing date

1992-07-23

Publication date

1998-05-15

1992-07-23 Application filed by Philippe Collery, Bernhard Keppler filed Critical Philippe Collery

1998-05-15 Application granted granted Critical

1998-05-15 Publication of ATE166056T1 publication Critical patent/ATE166056T1/de

Links

GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 title abstract 2
229910052733 gallium Inorganic materials 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
150000002431 hydrogen Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
208000036142 Viral infection Diseases 0.000 abstract 1
239000000460 chlorine Substances 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
125000001309 chloro group Chemical group Cl* 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000002346 iodo group Chemical group I* 0.000 abstract 1
229910021645 metal ion Inorganic materials 0.000 abstract 1
229910052700 potassium Inorganic materials 0.000 abstract 1
239000011591 potassium Substances 0.000 abstract 1
229910052708 sodium Inorganic materials 0.000 abstract 1
239000011734 sodium Substances 0.000 abstract 1
CYFLXLSBHQBMFT-UHFFFAOYSA-N sulfamoxole Chemical group O1C(C)=C(C)N=C1NS(=O)(=O)C1=CC=C(N)C=C1 CYFLXLSBHQBMFT-UHFFFAOYSA-N 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Pyridine Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT92916381T 1991-07-25 1992-07-23 Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten ATE166056T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP91402093		1991-07-25

Publications (1)

Publication Number	Publication Date
ATE166056T1 true ATE166056T1 (de)	1998-05-15

Family

ID=8208600

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92916381T ATE166056T1 (de)	1991-07-25	1992-07-23	Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten

Country Status (10)

Country	Link
US (1)	US5525598A (de)
EP (1)	EP0599881B1 (de)
JP (1)	JP3480498B2 (de)
AT (1)	ATE166056T1 (de)
AU (1)	AU2360092A (de)
CA (1)	CA2114136C (de)
DE (1)	DE69225484T2 (de)
ES (1)	ES2120450T3 (de)
GR (1)	GR3027634T3 (de)
WO (1)	WO1993002087A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5852146A (en) *	1996-06-27	1998-12-22	Union Carbide Chemicals & Plastics Technology Corporation	Catalyst for the production of olefin polymers
US6203822B1 (en) *	1996-09-03	2001-03-20	University Of Iowa Research Foundation	Gallium-containing compounds for the treatment of infections caused by intracellular pathogens and pathogens causing chronic pulmonary infection
WO2001024799A1 (en) *	1999-10-04	2001-04-12	Bernstein Lawrence R	Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses
US20020160055A1 (en) *	2000-09-18	2002-10-31	Jack Stapleton	Methods for treating human immunodeficiency virus infections with gallium compositions
DE10113185A1 (de) *	2001-03-19	2002-10-24	Faustus Forschungs Cie	Zusammensetzung, enthaltend einen Gallium(III)-Komplex und einen therapeutisch wirksamen Platin-Komplex
DE10116527C2 (de) *	2001-04-03	2003-05-15	Faustus Forschungs Cie	Tumorhemmende Galliumverbindungen, deren Verwendung als Arzneimittel sowie ein Arzneimittel, diese enthaltend
WO2005058331A1 (en) *	2003-12-17	2005-06-30	Titan Pharmaceuticals, Inc.	Use of gallium to treat inflammatory arthritis
US9345725B2 (en)	2004-12-29	2016-05-24	Emisphere Technologies, Inc.	Pharmaceutical formulations of gallium salts
AT501262B8 (de) *	2005-01-24	2007-02-15	Faustus Forschung Translationa	Verwendung von gallium(iii)-komplexen zur behandlung von tumoren des urothelialtraktes
AT501819B1 (de) *	2005-04-18	2007-01-15	Faustus Forschung Translationa	Verwendung von gallium(iii)-komplexen zur behandlung von tumorerkrankungen der leber
EP1993567A4 (de) *	2005-10-27	2011-01-26	Lawrence Richard Bernstein	Oral verabreichbare gallium-zusammensetzungen und anwendungsverfahren
US7354952B2 (en)	2005-11-04	2008-04-08	Genta Incorporated	Pharmaceutical gallium compositions and methods
US20070231406A1 (en) *	2006-01-30	2007-10-04	Bucalo Louis R	Use of gallium to treat biofilm-associated infections
AT503317B1 (de) *	2006-02-13	2007-09-15	Faustus Forschung Translationa	Verwendung von gallium(iii)-komplexen zur herstellung eines medikaments zur behandlung von melanomen
CA2656019C (en)	2006-06-28	2016-09-13	Emisphere Technologies, Inc.	Gallium nitrate formulations
WO2008058210A2 (en) *	2006-11-09	2008-05-15	Bernstein Lawrence R	Local administration of gallium compositions to treat pain
JP2012522789A (ja) *	2009-03-30	2012-09-27	ニッキファーマインク．	骨粗鬆症の治療法
EP2533781B1 (de) *	2010-02-12	2016-11-16	Niiki Pharma Inc.	Verfahren zur behandlung von blutkrebs myeloischen ursprungs
EP2538944B1 (de) *	2010-02-26	2014-10-22	Niiki Pharma Inc.	Verbindung zur behandlung von gehirntumoren
EP2560647B1 (de) *	2010-04-19	2016-04-13	Niiki Pharma Inc.	Kombinationstherapie mit einem proteasomhemmer und einem galliumkomplex
EP2560648A4 (de) *	2010-04-23	2013-10-02	Niiki Pharma Inc	Verfahren zur behandlung von bauchspeicheldrüsenkrebs
WO2012075210A2 (en) *	2010-12-01	2012-06-07	Niiki Pharma Inc.	Method for treating refractory cancer
US20120245135A1 (en)	2011-03-24	2012-09-27	Genta Incorporated	Gallium Complexes, Pharmaceutical Compositions And Methods Of Use
CN113372269A (zh) *	2021-06-25	2021-09-10	云南大学	一种席夫碱镓配合物及其制备方法和应用
CN115724863B (zh) *	2022-10-10	2025-07-25	中国科学院合肥物质科学研究院	具有可调谐绿色荧光的氧化镓团簇及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4373223A (en) *	1980-01-29	1983-02-15	Mildoy Enterprises	Container opener
EP0109564B1 (de) *	1982-10-22	1988-04-27	Sloan-Kettering Institute For Cancer Research	Verwendung von Gallium-Salzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Störungen der Calcium-Homöostasis
DE3240377A1 (de) *	1982-11-02	1984-05-03	Racek, Alfred, 1160 Wien	Feuerzeug

1992
- 1992-07-23 WO PCT/EP1992/001687 patent/WO1993002087A1/en not_active Ceased
- 1992-07-23 JP JP50260693A patent/JP3480498B2/ja not_active Expired - Fee Related
- 1992-07-23 AU AU23600/92A patent/AU2360092A/en not_active Abandoned
- 1992-07-23 CA CA002114136A patent/CA2114136C/en not_active Expired - Lifetime
- 1992-07-23 ES ES92916381T patent/ES2120450T3/es not_active Expired - Lifetime
- 1992-07-23 AT AT92916381T patent/ATE166056T1/de not_active IP Right Cessation
- 1992-07-23 US US08/178,241 patent/US5525598A/en not_active Expired - Lifetime
- 1992-07-23 DE DE69225484T patent/DE69225484T2/de not_active Expired - Fee Related
- 1992-07-23 EP EP92916381A patent/EP0599881B1/de not_active Expired - Lifetime
1998
- 1998-08-12 GR GR980401812T patent/GR3027634T3/el unknown

Also Published As

Publication number	Publication date
CA2114136A1 (en)	1993-02-04
GR3027634T3 (en)	1998-11-30
JPH07500575A (ja)	1995-01-19
EP0599881B1 (de)	1998-05-13
ES2120450T3 (es)	1998-11-01
EP0599881A1 (de)	1994-06-08
JP3480498B2 (ja)	2003-12-22
AU2360092A (en)	1993-02-23
US5525598A (en)	1996-06-11
DE69225484T2 (de)	1998-12-10
CA2114136C (en)	2003-07-29
DE69225484D1 (de)	1998-06-18
WO1993002087A1 (en)	1993-02-04

Similar Documents

Publication	Publication Date	Title
DE69225484D1 (de)	1998-06-18	Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
DE69104723D1 (de)	1994-11-24	Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
IL111077A (en)	1999-10-28	Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them
DZ1794A1 (fr)	2002-02-17	Nouvelle formule pharmaceutique.
NO952321D0 (no)	1995-06-13	Polypeptid, samt anti-HIV-preparat fremstilt fra dette
HUT77925A (hu)	1998-11-30	Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra
EP0482410A3 (en)	1992-09-09	Anti-microbial compounds, including substituted 2-cyclohexyl-amine derivatives and their preparation
ZA948670B (en)	1995-07-04	New benzoyl guanidine derivatives,the preparation thereof and their use in pharmaceutical compositions
IL108520A0 (en)	1994-05-30	Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
HUT77627A (hu)	1998-06-29	2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények
DE69409337D1 (de)	1998-05-07	Verzweigte Aminothiazole-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammenstellungen die sie enthalten
ATE38988T1 (de)	1988-12-15	Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE107167T1 (de)	1994-07-15	Pharmazeutische zubereitungen für neuroschutz, die arylcyclohexylamine enthalten.
ATE153342T1 (de)	1997-06-15	Adenosinderivate, verfahren zu deren herstellung und pharmazeutische mittel
NO972028D0 (no)	1997-04-30	Kjemiske forbindelser og antikonsepsjonsmidler inneholdende disse
ES8404852A1 (es)	1984-05-16	Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
DE69104220D1 (de)	1994-10-27	Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
HUT77768A (hu)	1998-08-28	N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
ES2017279A6 (es)	1991-01-16	Procedimiento para la obtencion de piperazinas y homopiperazinas substituidas.
ATE43350T1 (de)	1989-06-15	Nor-cholsaeure-derivate, verfahren zu ihrer herstellung, ihre anwendung und pharmazeutische zusammenstellungen, die sie enthalten.
GR3000773T3 (en)	1991-10-10	2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them
ATE144986T1 (de)	1996-11-15	Aminoacylderivate von gem- diphosphonsauren,verfahren zu deren herstellung und pharmazeutische zubereitungen,die sie enthalten
ATE145647T1 (de)	1996-12-15	Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
EP0387677A3 (en)	1990-12-05	Thienylacetic acid derivatives, process for their preparation, their application as well as pharmaceuticals containing them and their preparation
IL67400A0 (en)	1983-05-15	3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date	Code	Title
1999-02-15	UEP	Publication of translation of european patent specification
2002-04-15	EEIH	Change in the person of patent owner
2008-04-15	REN	Ceased due to non-payment of the annual fee